E. Wagner-Wysiecka et al. / Tetrahedron 63 (2007) 4414–4421
4419
1H NMR of crown ether 6 and its barium and lead(II) com-
plexes in d6-acetone; dH (ppm) is as follows:
128.9; 129.0; 133.0; 133.4; 135.3; 142.2; 142.8; 143.6;
154.7; 157.4; 158.3. IR nmax (film): 3554; 3502; 1587;
1300; 1274; 2222; 1158; 1062; 936; 758 cmꢃ1. HRMS (EI):
found [M]+¼454.1749; C25H22N6O3 requires 454.1753.
4.2.1.1. Crown 6. 8.12 (1H, s); 7.85 (1H, dd, J1¼1.5 Hz,
J2¼8.3 Hz, ArH); 7.79 (1H, dd, J1¼1.5 Hz, J2¼8.3 Hz,
ArH); 7.60 (1H, t, J¼8.3 Hz, ArH); 7.51 (1H, t, J¼8.7 Hz,
ArH); 7.33 (1H, d, J¼8.3 Hz, ArH); 7.28 (1H, d,
J¼8.7 Hz, ArH); 7.14–7.08 (2H, m); 4.41 (2H, t,
J¼4.4 Hz, ArOCH2); 4.39 (2H, t, J¼4.4 Hz, ArOCH2);
3.99 (2H, t, J¼4.4 Hz, ArOCH2CH2); 3.96 (2H, t,
J¼4.4 Hz, ArOCH2CH2); 3.82 (4H, s, central OCH2CH2O).
4.2.5. Azocrown 10: 21-membered derivative of 4-phe-
nylimidazole. Dark brownish-red solid from methylene
chloride–acetone, magenta dilute solution in acetone; mp
1
193–195 ꢁC. TLC, Rf w0.85 (CH2Cl2–methanol 15:2). H
NMR dH (ppm): 8.56–8.48 (2H, m, ArH); 8.10 (1H, d,
J¼7.8 Hz, ArH); 7.84 (1H, d, J¼7.8 Hz, ArH); 7.56–7.50
(2H, m, ArH); 7.49–7.36 (3H, m, ArH); 7.18–7.10 (4H, m,
ArH); 4.35–4.32 (4H, m, ArOCH2); 4.00–3.90 (4H, m, Ar-
OCH2CH2); 3.75 (4H, s, central OCH2CH2O). 13C NMR
dC (ppm): 29.6; 68.5; 68.5; 69.5; 70.8; 70.8; 113.6; 113.7;
117.2; 117.3; 121.7; 121.7; 128.7; 128.9; 129.2; 132.6;
134.6; 142.3; 142.5; 143.1; 156.7; 157.6. IR nmax (film):
3603; 1586; 1492; 1447; 1276; 1227; 1164; 1132; 1105;
1062; 940; 759 cmꢃ1. HRMS (EI): found [M]+¼498.2017;
C20H22N6O3 requires 498.2016.
4.2.1.2. Crown 6DBa(ClO4)2. 8.56 (1H, s); 7.85 (1H, d,
J¼7.8 Hz, ArH); 7.80 (1H, d, J¼7.8 Hz, ArH); 7.73 (1H,
t, J¼7.3 Hz, ArH); 7.63 (1H, t, J¼7.3 Hz, ArH); 7.48 (1H,
d, J¼8.3 Hz, ArH); 7.42 (1H, d, J¼8.3 Hz, ArH); 7.22–
7.17 (2H, m, ArH); 4.67 (2H, t, J¼3.9 Hz, ArOCH2);
4.64 (2H, t, J¼3.9 Hz, ArOCH2); 4.32 (2H, t, J¼3.9 Hz,
ArOCH2CH2); 4.29 (2H, t, J¼3.9 Hz, ArOCH2CH2); 4.10
(4H, s, central OCH2CH2O).
4.2.1.3. Crown 6DPb(ClO4)2. 8.82 (1H, s); 7.87 (1H, d,
J¼8.3 Hz, ArH); 7.83 (1H, d, J¼8.3 Hz, ArH); 7.79 (1H, t,
J¼7.3 Hz, ArH); 7.70 (1H, t, J¼8.3 Hz, ArH); 7.47–7.42
(2H, m, ArH); 7.26–7.20 (2H, m, ArH); 4.60 (4H, s, Ar-
OCH2); 4.25 (4H, s, ArOCH2CH2); 4.02 (4H, s, central
OCH2CH2O).
4.2.6. Azocrown 11: 17-membered derivative of 2-methyl-
imidazole. Brownish-red solid; mp 193–195 ꢁC. TLC, Rf
w0.45 (CH2Cl2–methanol 15:2). H NMR dH (ppm): 7.82
1
(2H, d, J¼7.8 Hz, ArH); 7.32–7.27 (2H, t, J¼7.3 Hz, ArH);
7.12–7.08 (2H, t, J¼7.3 Hz, ArH); 6.99 (2H, d, J¼8.3 Hz,
ArH); 4.25–4.15 (4H, m, ArOCH2); 4.00–3.85 (4H, m,
ArOCH2CH2); 2.60 (3H, s, CH3). 13C NMR dC (ppm):
15.0; 69.2; 70.0; 114.2; 121.4; 131.2; 131.6; 143.2;
147.5; 149.7. IR nmax (film): 3152; 1593; 1529; 1280;
1250; 1160; 1141; 1119; 1064; 940; 755 cmꢃ1. HRMS
(ESI): found [M+H]+¼393.1691; C20H20N6O3 requires
392.1691.
4.2.2. Azocrown 7: 18-membered derivative of 4-methyl-
imidazole. Deep red solid; mp 185–187 ꢁC. TLC, Rf w0.6
(CH2Cl2–methanol 15:2). H NMR dH (ppm): 8.00–7.80
1
(2H, m, ArH); 7.55–7.35 (2H, m, ArH); 7.20–7.05 (4H, m,
ArH); 4.35–4.30 (4H, m, ArOCH2); 4.10–3.95 (4H, m, Ar-
OCH2CH2); 2.75 (3H, s, CH3). 13C NMR dC (ppm): 12.7;
71.1; 71.3; 116.1; 116.5; 117.9; 123.0; 123.1; 133.2; 135.5,
142.7; 142.9; 157.3; 158.4. IR nmax (film): 3442; 1591; 1547;
1264; 1134; 1055; 1012; 754; 616 cmꢃ1. HRMS (EI): found
[M]+¼392.1587; C20H20N6O3 requires 392.1597.
4.2.7. Azocrown 12: 20-membered derivative of 2-methyl-
imidazole. Dark brownish-red solid; mp 135–138 ꢁC.
TLC, Rf w0.5 (CH2Cl2–methanol 15:2). 1H NMR dH
(ppm): 7.53 (2H, d, J¼7.3 Hz, ArH); 7.34 (2H, t,
J¼8.3 Hz, ArH); 7.06 (2H, d, J¼8.3 Hz, ArH); 7.01 (2H, t,
J¼7.8 Hz, ArH); 4.34–4.26 (4H, m, ArOCH2); 3.64–3.58
(4H, m, ArOCH2CH2); 3.32 (4H, s, central OCH2CH2O);
2.6 (3H, s, CH3). 13C NMR dC (ppm): 14.9; 70.5; 71.2;
117.5; 120.0; 122.0; 132.0; 145.2; 146.9; 155.5. IR nmax
(film): 3466; 1589; 1504; 1283; 1244; 1227; 1111; 1042;
941; 754 cmꢃ1. HRMS (ESI): found [M+H]+¼437.1962;
C22H24N6O4 requires 436.1962.
4.2.3. Azocrown 8: 21-membered derivative of 4-methyl-
imidazole. Dark red solid crystallized from acetone; mp
1
162–166 ꢁC. TLC, Rf w0.75 (CH2Cl2–methanol 15:2). H
NMR dH (ppm): 7.95 (1H, d, J¼8.3 Hz, ArH); 7.84 (1H, d,
J¼7.8 Hz, ArH); 7.44 (1H, t, J¼7.3 Hz, ArH); 7.35 (1H, t,
J¼7.4 Hz, ArH); 7.06–7.00 (4H, m, ArH); 4.38–4.28 (4H,
m, ArOCH2); 4.00–3.90 (4H, m, ArOCH2CH2); 3.79 (4H,
s, central OCH2CH2O); 2.80 (3H, s CH3). 13C NMR dC
(ppm): 13.2; 68.7; 68.7; 69.6; 69.7; 70.8; 70.9; 113.7;
113.9; 116.7; 117.0; 121.6; 121.7; 132.0; 134.1; 142.5;
142.7; 143.0; 147.6; 155.1; 156.4; 157.5. IR nmax (film):
3478, 1584, 1538, 1350, 1304, 1275, 1242, 1221, 1197,
4.2.8. 5-Ethyl-2-nitro-phenol (13). To a solution of 3-ethyl-
phenol (7.32 g, 60 mmol) in a mixture of 500 cm3 chloro-
form and 80 cm3 glacial acetic acid, concd nitric acid
(4.60 cm3) in acetic acid (80 cm3) was added dropwise
with stirring at room temperature. Stirring was continued
for 4 h. The mixture was diluted with water. The organic
layer was separated and washed with sodium bicarbonate
solution and evaporated. The residue was chromatographed
on column using methylene chloride–petroleum ether (1:2)
mixture as an eluent. The first fraction contains yellow
oily product. 1H NMR dH (ppm): 10.7 (1H, s, ArOH);
8.02 (1H, d, J¼8.7 Hz, ArH); 7.02 (1H, d, J¼1.9 Hz,
ArH); 6.86 (1H, dd, J¼1.9 Hz, J¼8.7 Hz, ArH); 2.70
(2H, q, J¼7.6 Hz, ArCH2); 1.30 (3H, t, J¼7.5 Hz,
ArCH2CH3). MS (EI): found [M]+¼167; C8H9NO3 requires
167.
1156, 1105, 954, 757 cmꢃ1
. HRMS (ESI): found
[M]+¼436.1956; C22H25N6O4 requires 436.1956.
4.2.4. Azocrown 9: 18-membered derivative of 4-phenyl-
imidazole. Dark red-violet solid; mp 186–190 ꢁC. TLC, Rf
1
w0.6 (CH2Cl2–methanol 15:2). H NMR dH (ppm): 8.58–
8.55 (2H, m, ArH); 8.10 (1H, dd, J1¼6.4 Hz, J2¼1.5 Hz,
ArH); 7.94–7.90 (1H, dd, J1¼6.8Hz, J2¼1.5Hz, ArH);
7.58–7.50 (3H, m, ArH); 7.49–7.42 (2H, m, ArH); 7.20–
7.10 (4H, m, ArH); 4.50–4.48 (4H, m, ArOCH2); 4.15–
4.00 (4H, m, ArOCH2CH2). 13C NMR dC (ppm): 70.2;
71.0; 71.2; 116.3; 116.5; 116.6; 116.7; 122.6; 128.5;